Pharmaceuticals

Global Deferasirox Market Professional Survey Report 2018

  • QYR2636413
  • 102 Pages
  • July 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies the global Deferasirox market status and forecast, categorizes the global Deferasirox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.

The global Deferasirox market is valued at 2270 million US$ in 2017 and will reach 3230 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2018-2025.

The major manufacturers covered in this report

Novartis

Cipla

Sun Pharma

Natco Pharma

...

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

India

Southeast Asia

Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

500 mg/Tablet

250 mg/Tablet

125 mg/Tablet

Others

By Application, the market can be split into

Transfusional Iron Overload

NTDT Caused Iron Overload

The study objectives of this report are:

To analyze and study the global Deferasirox capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

Focuses on the key Deferasirox manufacturers, to study the capacity, production, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Deferasirox are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Deferasirox Manufacturers

Deferasirox Distributors/Traders/Wholesalers

Deferasirox Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Deferasirox market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Deferasirox Market Professional Survey Report 2018

1 Industry Overview of Deferasirox

1.1 Definition and Specifications of Deferasirox

1.1.1 Definition of Deferasirox

1.1.2 Specifications of Deferasirox

1.2 Classification of Deferasirox

1.2.1 500 mg/Tablet

1.2.2 250 mg/Tablet

1.2.3 125 mg/Tablet

1.2.4 Others

1.3 Applications of Deferasirox

1.3.1 Transfusional Iron Overload

1.3.2 NTDT Caused Iron Overload

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 Europe

1.4.3 China

1.4.4 Japan

1.4.5 Southeast Asia

1.4.6 India

2 Manufacturing Cost Structure Analysis of Deferasirox

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Deferasirox

2.3 Manufacturing Process Analysis of Deferasirox

2.4 Industry Chain Structure of Deferasirox

3 Technical Data and Manufacturing Plants Analysis of Deferasirox

3.1 Capacity and Commercial Production Date of Global Deferasirox Major Manufacturers in 2017

3.2 Manufacturing Plants Distribution of Global Deferasirox Major Manufacturers in 2017

3.3 R&D Status and Technology Source of Global Deferasirox Major Manufacturers in 2017

3.4 Raw Materials Sources Analysis of Global Deferasirox Major Manufacturers in 2017

4 Global Deferasirox Overall Market Overview

4.1 2013-2018E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2013-2018E Global Deferasirox Capacity and Growth Rate Analysis

4.2.2 2017 Deferasirox Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2013-2018E Global Deferasirox Sales and Growth Rate Analysis

4.3.2 2017 Deferasirox Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2013-2018E Global Deferasirox Sales Price

4.4.2 2017 Deferasirox Sales Price Analysis (Company Segment)

5 Deferasirox Regional Market Analysis

5.1 North America Deferasirox Market Analysis

5.1.1 North America Deferasirox Market Overview

5.1.2 North America 2013-2018E Deferasirox Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2013-2018E Deferasirox Sales Price Analysis

5.1.4 North America 2017 Deferasirox Market Share Analysis

5.2 Europe Deferasirox Market Analysis

5.2.1 Europe Deferasirox Market Overview

5.2.2 Europe 2013-2018E Deferasirox Local Supply, Import, Export, Local Consumption Analysis

5.2.3 Europe 2013-2018E Deferasirox Sales Price Analysis

5.2.4 Europe 2017 Deferasirox Market Share Analysis

5.3 China Deferasirox Market Analysis

5.3.1 China Deferasirox Market Overview

5.3.2 China 2013-2018E Deferasirox Local Supply, Import, Export, Local Consumption Analysis

5.3.3 China 2013-2018E Deferasirox Sales Price Analysis

5.3.4 China 2017 Deferasirox Market Share Analysis

5.4 Japan Deferasirox Market Analysis

5.4.1 Japan Deferasirox Market Overview

5.4.2 Japan 2013-2018E Deferasirox Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Japan 2013-2018E Deferasirox Sales Price Analysis

5.4.4 Japan 2017 Deferasirox Market Share Analysis

5.5 Southeast Asia Deferasirox Market Analysis

5.5.1 Southeast Asia Deferasirox Market Overview

5.5.2 Southeast Asia 2013-2018E Deferasirox Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Southeast Asia 2013-2018E Deferasirox Sales Price Analysis

5.5.4 Southeast Asia 2017 Deferasirox Market Share Analysis

5.6 India Deferasirox Market Analysis

5.6.1 India Deferasirox Market Overview

5.6.2 India 2013-2018E Deferasirox Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2013-2018E Deferasirox Sales Price Analysis

5.6.4 India 2017 Deferasirox Market Share Analysis

6 Global 2013-2018E Deferasirox Segment Market Analysis (by Type)

6.1 Global 2013-2018E Deferasirox Sales by Type

6.2 Different Types of Deferasirox Product Interview Price Analysis

6.3 Different Types of Deferasirox Product Driving Factors Analysis

6.3.1 500 mg/Tablet Growth Driving Factor Analysis

6.3.2 250 mg/Tablet Growth Driving Factor Analysis

6.3.3 125 mg/Tablet Growth Driving Factor Analysis

6.3.4 Others Growth Driving Factor Analysis

7 Global 2013-2018E Deferasirox Segment Market Analysis (by Application)

7.1 Global 2013-2018E Deferasirox Consumption by Application

7.2 Different Application of Deferasirox Product Interview Price Analysis

7.3 Different Application of Deferasirox Product Driving Factors Analysis

7.3.1 Transfusional Iron Overload of Deferasirox Growth Driving Factor Analysis

7.3.2 NTDT Caused Iron Overload of Deferasirox Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Deferasirox

8.1 Novartis

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Product A

8.1.2.2 Product B

8.1.3 Novartis 2017 Deferasirox Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Novartis 2017 Deferasirox Business Region Distribution Analysis

8.2 Cipla

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Product A

8.2.2.2 Product B

8.2.3 Cipla 2017 Deferasirox Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Cipla 2017 Deferasirox Business Region Distribution Analysis

8.3 Sun Pharma

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Product A

8.3.2.2 Product B

8.3.3 Sun Pharma 2017 Deferasirox Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 Sun Pharma 2017 Deferasirox Business Region Distribution Analysis

8.4 Natco Pharma

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Product A

8.4.2.2 Product B

8.4.3 Natco Pharma 2017 Deferasirox Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Natco Pharma 2017 Deferasirox Business Region Distribution Analysis

9 Development Trend of Analysis of Deferasirox Market

9.1 Global Deferasirox Market Trend Analysis

9.1.1 Global 2018-2025 Deferasirox Market Size (Volume and Value) Forecast

9.1.2 Global 2018-2025 Deferasirox Sales Price Forecast

9.2 Deferasirox Regional Market Trend

9.2.1 North America 2018-2025 Deferasirox Consumption Forecast

9.2.2 Europe 2018-2025 Deferasirox Consumption Forecast

9.2.3 China 2018-2025 Deferasirox Consumption Forecast

9.2.4 Japan 2018-2025 Deferasirox Consumption Forecast

9.2.5 Southeast Asia 2018-2025 Deferasirox Consumption Forecast

9.2.6 India 2018-2025 Deferasirox Consumption Forecast

9.3 Deferasirox Market Trend (Product Type)

9.4 Deferasirox Market Trend (Application)

10 Deferasirox Marketing Type Analysis

10.1 Deferasirox Regional Marketing Type Analysis

10.2 Deferasirox International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Deferasirox by Region

10.4 Deferasirox Supply Chain Analysis

11 Consumers Analysis of Deferasirox

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Deferasirox Market Professional Survey Report 2017

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Deferasirox

Table Product Specifications of Deferasirox

Table Classification of Deferasirox

Figure Global Production Market Share of Deferasirox by Type in 2017

Figure 500 mg/Tablet Picture

Table Major Manufacturers of 500 mg/Tablet

Figure 250 mg/Tablet Picture

Table Major Manufacturers of 250 mg/Tablet

Figure 125 mg/Tablet Picture

Table Major Manufacturers of 125 mg/Tablet

Figure Others Picture

Table Major Manufacturers of Others

Table Applications of Deferasirox

Figure Global Consumption Volume Market Share of Deferasirox by Application in 2017

Figure Transfusional Iron Overload Examples

Table Major Consumers in Transfusional Iron Overload

Figure NTDT Caused Iron Overload Examples

Table Major Consumers in NTDT Caused Iron Overload

Figure Market Share of Deferasirox by Regions

Figure North America Deferasirox Market Size (Million USD) (2013-2025)

Figure Europe Deferasirox Market Size (Million USD) (2013-2025)

Figure China Deferasirox Market Size (Million USD) (2013-2025)

Figure Japan Deferasirox Market Size (Million USD) (2013-2025)

Figure Southeast Asia Deferasirox Market Size (Million USD) (2013-2025)

Figure India Deferasirox Market Size (Million USD) (2013-2025)

Table Deferasirox Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Deferasirox in 2017

Figure Manufacturing Process Analysis of Deferasirox

Figure Industry Chain Structure of Deferasirox

Table Capacity and Commercial Production Date of Global Deferasirox Major Manufacturers in 2017

Table Manufacturing Plants Distribution of Global Deferasirox Major Manufacturers in 2017

Table R&D Status and Technology Source of Global Deferasirox Major Manufacturers in 2017

Table Raw Materials Sources Analysis of Global Deferasirox Major Manufacturers in 2017

Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Deferasirox 2013-2018E

Figure Global 2013-2018E Deferasirox Market Size (Volume) and Growth Rate

Figure Global 2013-2018E Deferasirox Market Size (Value) and Growth Rate

Table 2013-2018E Global Deferasirox Capacity and Growth Rate

Table 2017 Global Deferasirox Capacity (M Tablets) List (Company Segment)

Table 2013-2018E Global Deferasirox Sales (M Tablets) and Growth Rate

Table 2017 Global Deferasirox Sales (M Tablets) List (Company Segment)

Table 2013-2018E Global Deferasirox Sales Price (USD/Tablet)

Table 2017 Global Deferasirox Sales Price (USD/Tablet) List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption (M Tablets) of Deferasirox 2013-2018E

Figure North America 2013-2018E Deferasirox Sales Price (USD/Tablet)

Figure North America 2017 Deferasirox Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption (M Tablets) of Deferasirox 2013-2018E

Figure Europe 2013-2018E Deferasirox Sales Price (USD/Tablet)

Figure Europe 2017 Deferasirox Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption (M Tablets) of Deferasirox 2013-2018E

Figure China 2013-2018E Deferasirox Sales Price (USD/Tablet)

Figure China 2017 Deferasirox Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption (M Tablets) of Deferasirox 2013-2018E

Figure Japan 2013-2018E Deferasirox Sales Price (USD/Tablet)

Figure Japan 2017 Deferasirox Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption (M Tablets) of Deferasirox 2013-2018E

Figure Southeast Asia 2013-2018E Deferasirox Sales Price (USD/Tablet)

Figure Southeast Asia 2017 Deferasirox Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption (M Tablets) of Deferasirox 2013-2018E

Figure India 2013-2018E Deferasirox Sales Price (USD/Tablet)

Figure India 2017 Deferasirox Sales Market Share

Table Global 2013-2018E Deferasirox Sales (M Tablets) by Type

Table Different Types Deferasirox Product Interview Price

Table Global 2013-2018E Deferasirox Sales (M Tablets) by Application

Table Different Application Deferasirox Product Interview Price

Table Novartis Information List

Table Product Overview

Table 2017 Novartis Deferasirox Revenue (Million USD), Sales (M Tablets), Ex-factory Price (USD/Tablet)

Figure 2017 Novartis Deferasirox Business Region Distribution

Table Cipla Information List

Table Product Overview

Table 2017 Cipla Deferasirox Revenue (Million USD), Sales (M Tablets), Ex-factory Price (USD/Tablet)

Figure 2017 Cipla Deferasirox Business Region Distribution

Table Sun Pharma Information List

Table Product Overview

Table 2017 Sun Pharma Deferasirox Revenue (Million USD), Sales (M Tablets), Ex-factory Price (USD/Tablet)

Figure 2017 Sun Pharma Deferasirox Business Region Distribution

Table Natco Pharma Information List

Table Product Overview

Table 2017 Natco Pharma Deferasirox Revenue (Million USD), Sales (M Tablets), Ex-factory Price (USD/Tablet)

Figure 2017 Natco Pharma Deferasirox Business Region Distribution

Figure Global 2018-2025 Deferasirox Market Size (M Tablets) and Growth Rate Forecast

Figure Global 2018-2025 Deferasirox Market Size (Million USD) and Growth Rate Forecast

Figure Global 2018-2025 Deferasirox Sales Price (USD/Tablet) Forecast

Figure North America 2018-2025 Deferasirox Consumption Volume (M Tablets) and Growth Rate Forecast

Figure China 2018-2025 Deferasirox Consumption Volume (M Tablets) and Growth Rate Forecast

Figure Europe 2018-2025 Deferasirox Consumption Volume (M Tablets) and Growth Rate Forecast

Figure Southeast Asia 2018-2025 Deferasirox Consumption Volume (M Tablets) and Growth Rate Forecast

Figure Japan 2018-2025 Deferasirox Consumption Volume (M Tablets) and Growth Rate Forecast

Figure India 2018-2025 Deferasirox Consumption Volume (M Tablets) and Growth Rate Forecast

Table Global Sales Volume (M Tablets) of Deferasirox by Type 2018-2025

Table Global Consumption Volume (M Tablets) of Deferasirox by Application 2018-2025

Table Traders or Distributors with Contact Information of Deferasirox by Region

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370